Market Overview

UPDATE: Citigroup Reiterates Illumina at Neutral on Valuation

Share:
Related ILMN
The Market In 5 Minutes: Up And Down Week Comes To A Close
Benzinga's M&A Chatter for Thursday August 18, 2016
Illumina Deserves Its Valuation (Seeking Alpha)

Citigroup maintained Illumina (NASDAQ: ILMN) at Neutral with a $51 price target.

Citigroup commented, "We expect the stock to be under pressure today as investors question the deal valuation/near-term $0.20 EPS dilution of the Verinata deal, the longer term impact of ILMN competing with its own customers (i.e., SQNM), and the level (if any) of Roche takeout premium to still ascribe to the stock. We remain on the sidelines on ILMN stock given the stock's current multiple and level of investment required/EPS power for the company in 2013."

Illumina closed at $54.76 on Friday.

Latest Ratings for ILMN

DateFirmActionFromTo
Aug 2016CL KingDowngradesBuyNeutral
Aug 2016Argus ResearchMaintainsBuy
Jul 2016JP MorganMaintainsOverweight

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Reiteration Intraday Update Analyst Ratings

 

Related Articles (ILMN)

View Comments and Join the Discussion!